Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 214 of the 216 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for management of osteoporosis in men. EVIDENCE: We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and evidence quality. CONSENSUS PROCESS: Consensus was guided by systematic evidence reviews, one in-person meeting, and multiple conference calls and e-mails. Task Force drafts were reviewed successively by The Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee; representatives of ASBMR, ECTS, ESE, ISCD; and members at large. At each stage, the Task Force received written comments and incorporated needed changes. The reviewed document was approved by The Endocrine Society Council before submission for peer review. CONCLUSIONS: Osteoporosis in men causes significant morbidity and mortality. We recommend testing higher risk men [aged ≥70 and men aged 50-69 who have risk factors (e.g. low body weight, prior fracture as an adult, smoking, etc.)] using central dual-energy x-ray absorptiometry. Laboratory testing should be done to detect contributing causes. Adequate calcium and vitamin D and weight-bearing exercise should be encouraged; smoking and excessive alcohol should be avoided. Pharmacological treatment is recommended for men aged 50 or older who have had spine or hip fractures, those with T-scores of -2.5 or below, and men at high risk of fracture based on low bone mineral density and/or clinical risk factors. Treatment should be monitored with serial dual-energy x-ray absorptiometry testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Laboratory testing is indicated to exclude secondary causes of osteoporosis [1, 14, 17] (Table 4).”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [17]
In the citing paper
“The Endocrine Society recommended that men with high fracture risk should receive an agent with proven antifracture activity irrespective of receiving testosterone or not (50).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [50]
Citations
Cites
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Johnell, O., & Kanis, J. A. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0172-4 · Cited by 4,704
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2704 · Cited by 4,026
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Epidemiology of adult fractures: A review
Court-Brown, C. M., & Caesar, B. (2006) · Injury · doi:10.1016/j.injury.2006.04.130 · Cited by 3,672
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Self-citationVitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689 · cited 2×
“Vitamin D at high doses may result in toxicity (hypercalcemia or hypercalciuria), but this is rarely seen unless 25(OH)D levels exceed 150 ng/ml (375 nmol/liter) (121), and such levels are unlikely with the doses of vitamin D recommended here.”
Background
Research works printed but not linked: 4
- Rao, 1996, Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders, 306
- Siegel, 1995, Metabolic bone diseases and disorders of the gastrointestinal tract, 113
- Barragry, 1978, Intestinal cholecalciferol absorption in the elderly and in young subjects., Clin Sci Mol Med, 55, 213
- Finkelstein, 2008, Toward a physiologically-based definition of hypogonadism in men: dose-response relationship between testosterone and bone resorption (Abstract 1102). ASBMR 30th Annual Meeting 1001–1300., J Bone Miner Res, 23, S2
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
UK clinical guideline for the prevention and treatment of osteoporosis
The National Osteoporosis Guideline Group (NOGG), Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 826
Osteoporosis: A Review of Treatment Options.
Tu, K. N., Lie, J. D., Wan, C. K. V., Cameron, M., Austel, A. G., Nguyen, J. K., Van, K., & Hyun, D. (2018) · PubMed Central · Cited by 735
Ensrud, K. E., & Crandall, C. J. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201708010 · Cited by 726
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.7498 · Cited by 665
Gender Disparities in Osteoporosis
Alswat, K. A. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2970w · Cited by 596
“However, it is still useful and recommended to be used for fracture risk predictions in men and women [30].”
BackgroundUK clinical guideline for the prevention and treatment of osteoporosis
Gregson, C. L., Armstrong, D. J., Bowden, J., Cooper, C., Edwards, J., Gittoes, N. J. L., Harvey, N., Kanis, J., Leyland, S., Low, R., et al. (2022) · Archives of Osteoporosis · doi:10.1007/s11657-022-01061-5 · Cited by 593
The Advisory Board of the National Osteoporosis Guideline Group, Kanis, J. A., Harvey, N. C., Cooper, C., Johansson, H., Odén, A., & McCloskey, E. V. (2016) · Archives of Osteoporosis · doi:10.1007/s11657-016-0278-z · Cited by 421
American Cancer Society prostate cancer survivorship care guidelines
Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., Salner, A. L., Zelefsky, M. J., Aragon‐Ching, J. B., Slovin, S. F., et al. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21234 · Cited by 398
The Effectiveness of Physical Exercise on Bone Density in Osteoporotic Patients
Benedetti, M. G., Furlini, G., Zati, A., & Letizia Mauro, G. (2018) · BioMed Research International · doi:10.1155/2018/4840531 · Cited by 395
Testosterone and Cardiovascular Disease
Kloner, R. A., Carson, C., Dobs, A., Kopecky, S., & Mohler, E. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.005 · Cited by 371
Jang, S., Graffy, P. M., Ziemlewicz, T. J., Lee, S. J., Summers, R. M., & Pickhardt, P. J. (2019) · Radiology · doi:10.1148/radiol.2019181648 · Cited by 362
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 338
Lewiecki, E. M., Blicharski, T., Goemaere, S., Lippuner, K., Meisner, P. D., Miller, P. D., Miyauchi, A., Maddox, J., Chen, L., & Horlait, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02163 · Cited by 328
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow
Taylor, A. E., Keevil, B., & Huhtaniemi, I. T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0338 · Cited by 320
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015) · The Aging Male · doi:10.3109/13685538.2015.1004049 · Cited by 312
The Pathophysiology and Treatment of Osteoporosis
Drake, M. T., Clarke, B. L., & Lewiecki, E. M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.06.006 · Cited by 290
Self-citationMolecular Mechanisms and Emerging Therapeutics for Osteoporosis
Noh, J.-Y., Yang, Y., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207623 · Cited by 287
Murad, M. H., Drake, M. T., Mullan, R. J., Mauck, K. F., Stuart, L. M., Lane, M. A., Abu Elnour, N. O., Erwin, P. J., Hazem, A., Puhan, M. A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3060 · Cited by 277
Self-citationGuidelines for the diagnosis, prevention and management of osteoporosis
Rossini, M., Adami, S., Bertoldo, F., Diacinti, D., Gatti, D., Giannini, S., Giusti, A., Malavolta, N., Minisola, S., Osella, G., et al. (2016) · Reumatismo · doi:10.4081/reumatismo.2016.870 · Cited by 272
Grossmann, M., & Matsumoto, A. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3580 · Cited by 246
Osteoporosis in Men: A Review of an Underestimated Bone Condition
Rinonapoli, G., Ruggiero, C., Meccariello, L., Bisaccia, M., Ceccarini, P., & Caraffa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042105 · Cited by 245
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition
Conley, R. B., Adib, G., Adler, R. A., Åkesson, K. E., Alexander, I. M., Amenta, K. C., Blank, R. D., Brox, W. T., Carmody, E. E., Chapman-Novakofski, K., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3877 · Cited by 242
Self-citationClinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review
Bartz, D., Chitnis, T., Kaiser, U. B., Rich-Edwards, J. W., Rexrode, K. M., Pennell, P. B., Goldstein, J. M., O’Neal, M. A., LeBoff, M., Behn, M., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.7194 · Cited by 239
Vilaca, T., Eastell, R., & Schini, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00012-2 · Cited by 210
Self-citationOsteoporosis – a current view of pharmacological prevention and treatment
Crockett, J., & Das (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s31504 · Cited by 206
Tarantino, U., Iolascon, G., Cianferotti, L., Masi, L., Marcucci, G., Giusti, F., Marini, F., Parri, S., Feola, M., Rao, C., et al. (2017) · Journal of Orthopaedics and Traumatology · doi:10.1007/s10195-017-0474-7 · Cited by 201
Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people
Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199
Gonadal steroid–dependent effects on bone turnover and bone mineral density in men
Finkelstein, J. S., Lee, H., Leder, B. Z., Burnett-Bowie, S.-A. M., Goldstein, D. W., Hahn, C. W., Hirsch, S. C., Linker, A., Perros, N., Servais, A. B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84137 · Cited by 198
“In the absence of data demonstrating that testosterone administration reduces fracture risk, and in light of controversial data suggesting that testosterone administration may increase the risk of cardiovascular disease (39, 40), current guidelines recommend that the use of testosterone for bone health in hypogonadal…”
BackgroundSelf-citationThe clinical epidemiology of male osteoporosis: a review of the recent literature
Nelson, R., Willson, T., Nelson, S., Newbold, J., & LaFleur, J. (2015) · Clinical Epidemiology · doi:10.2147/clep.s40966 · Cited by 190
Ensrud, K. E., & Crandall, C. J. (2024) · Annals of Internal Medicine · doi:10.7326/aitc202401160 · Cited by 186
Isidori, A. M., Aversa, A., Calogero, A. E., Ferlin, A., Francavilla, S., Lanfranco, F., Pivonello, R., Rochira, V., Corona, G., & Maggi, M. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01859-7 · Cited by 182
Bone Health and Osteoporosis Prevention and Treatment
MUÑOZ, M., ROBINSON, K., & Shibli-Rahhal, A. A. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000572 · Cited by 177
Testosterone and Bone Health in Men: A Narrative Review
Shigehara, K., Izumi, K., Kadono, Y., & Mizokami, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030530 · Cited by 170
COPD and osteoporosis: links, risks, and treatment challenges
Inoue, D., Watanabe, R., & Okazaki, R. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s79638 · Cited by 167
New horizons in treatment of osteoporosis
Tabatabaei-Malazy, O., Salari, P., Khashayar, P., & Larijani, B. (2017) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-017-0167-z · Cited by 166
Diagnosis and Management of Vertebral Compression Fracture
Alsoof, D., Anderson, G., McDonald, C. L., Basques, B. A., Kuris, E. O., & Daniels, A. H. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.02.035 · Cited by 161
Gender Differences in Osteoporosis: A Single-Center Observational Study
Martinis, M. D., Sirufo, M. M., Polsinelli, M., Placidi, G., Silvestre, D. D., & Ginaldi, L. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.200099 · Cited by 160
Evidence-Based Guideline for the management of osteoporosis in men
Fuggle, N. R., Beaudart, C., Bruyère, O., Abrahamsen, B., Al‐Daghri, N. M., Burlet, N., Chandran, M., Rosa, M. M., Cortet, B., Demonceau, C., et al. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01094-9 · Cited by 159
The effect of physical exercise on bone density in middle-aged and older men: A systematic review
Bolam, K. A., van Uffelen, J. G. Z., & Taaffe, D. R. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2346-1 · Cited by 158
The 2024 UK clinical guideline for the prevention and treatment of osteoporosis
Gregson, C. L., Armstrong, D., Avgerinou, C., Bowden, J., Cooper, C. C., Douglas, L., Edwards, J., Gittoes, N. J. L., Harvey, N. C., Kanis, J. A., et al. (2025) · Archives of Osteoporosis · doi:10.1007/s11657-025-01588-3 · Cited by 157
Dual energy X-ray absorptiometry: Pitfalls in measurement and interpretation of bone mineral density
Garg, M., & Kharb, S. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.109659 · Cited by 156
Golds, G., Houdek, D., & Arnason, T. (2017) · International Journal of Endocrinology · doi:10.1155/2017/4602129 · Cited by 150
Muscle and Bone Mass Loss in the Elderly Population: Advances in diagnosis and treatment
Colón, C. J. P., Molina-Vicenty, I. L., Frontera-Rodríguez, M., García-Ferré, A., Rivera, B. P., Cintrón-Vélez, G., & Frontera-Rodríguez, S. (2018) · Journal of Biomedicine · doi:10.7150/jbm.23390 · Cited by 150
Adler, R. A. (2014) · Bone Research · doi:10.1038/boneres.2014.1 · Cited by 128
Self-citationTesticular function and bone metabolism—beyond testosterone
Ferlin, A., Selice, R., Carraro, U., & Foresta, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.135 · Cited by 117
Osteoporosis treatment: current drugs and future developments
Chen, Y., Jia, L.-H., Han, T.-H., Zhao, Z., Yang, J. M., Xiao, J., Yang, H., & Yang, K. Q. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1456796 · Cited by 107
Recomendaciones de la Sociedad Española de Reumatología sobre osteoporosis
Naranjo, A., Fontecha, P. D. D. C., Acín, M. P. A., Rodríguez, L. M. A., Casado, E., Castañeda, S., Aresté, J. F., Gifre, L., Vaquero, C. G., Candelas, G., et al. (2018) · Reumatología Clínica · doi:10.1016/j.reuma.2018.09.004 · Cited by 104
Bandeira, L., Silva, B. C. C., & Bilezikian, J. P. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000563 · Cited by 102
Self-citationManagement of cancer treatment-induced bone loss
Coleman, R. E., Rathbone, E. J., & Brown, J. E. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.36 · Cited by 102
Androgens and prostate cancer; pathogenesis and deprivation therapy
Grossmann, M., Cheung, A. S., & Zajac, J. D. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.001 · Cited by 97
Testosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
Bone health in diabetes and prediabetes
Costantini, S., & Conte, C. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i8.421 · Cited by 95
Saylor, P. J., Rumble, R. B., Tagawa, S. T., Eastham, J. A., Finelli, A., Reddy, P. S., Kungel, T. M., Nissenberg, M. G., & Michalski, J. M. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03148 · Cited by 91
EAA clinical guideline on management of bone health in the andrological outpatient clinic
Rochira, V., Antonio, L., & Vanderschueren, D. (2018) · Andrology · doi:10.1111/andr.12470 · Cited by 89
Fuleihan, G. E., Chakhtoura, M., Cauley, J. A., & Chamoun, N. (2017) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2017.06.008 · Cited by 89
A Review of Osteoporosis in the Older Adult
Alejandro, P., & Constantinescu, F. (2018) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2018.03.004 · Cited by 87
Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
Cannarella, R., Barbagallo, F., Condorelli, R. A., Aversa, A., Vignera, S. L., & Calogero, A. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101564 · Cited by 83
Management of Osteoporosis in Men: A Narrative Review
Vescini, F., Chiodini, I., Falchetti, A., Palermo, A., Salcuni, A. S., Bonadonna, S., Geronimo, V. D., Cesareo, R., Giovanelli, L., Brigo, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413640 · Cited by 82
Osteoporosis Diagnosis in Men: The T-Score Controversy Revisited
Binkley, N., Adler, R. A., & Bilezikian, J. P. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0242-z · Cited by 82
Self-citationChallenges and improvements in testosterone and estradiol testing
Vesper, H., Botelho, J., & Wang, Y. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122338 · Cited by 81
Jiang, Y., Zhang, Y., Jin, M., Gu, Z., Pei, Y., & Meng, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130400 · Cited by 80
The 2018 Guidelines for the diagnosis and treatment of osteoporosis in Greece
Makras, P., Anastasilakis, A. D., Antypas, G. D., Chronopoulos, E., Kaskani, E., Matsouka, A., Patrikos, D., Stathopoulos, K. D., Tournis, S., Trovas, G., et al. (2019) · Archives of Osteoporosis · doi:10.1007/s11657-019-0584-3 · Cited by 80
Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta‐Analysis
Nayak, S., & Greenspan, S. L. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14668 · Cited by 79
Exercise and bone mineral density in men: A meta-analysis of randomized controlled trials
Kelley, G. A., Kelley, K. S., & Kohrt, W. M. (2012) · Bone · doi:10.1016/j.bone.2012.11.031 · Cited by 78
Adler, R. A. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.05.007 · Cited by 78
Self-citationTestosterone supplementation and bone parameters: a systematic review and meta-analysis study
Corona, G., Vena, W., Pizzocaro, A., Giagulli, V. A., Francomano, D., Rastrelli, G., Mazziotti, G., Aversa, A., Isidori, A. M., Pivonello, R., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01702-5 · Cited by 77
Disparities in Osteoporosis Prevention and Care: Understanding Gender, Racial, and Ethnic Dynamics
Onizuka, N., & Onizuka, T. (2024) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-024-09909-8 · Cited by 77
Friedreich Ataxia: Multidisciplinary Clinical Care
Lynch, D. R., Schadt, K. A., Kichula, E. A., McCormack, S. E., & Lin, K. Y. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s292945 · Cited by 75
Updated approach for the management of osteoporosis in Turkey: a consensus report
Kirazlı, Y., Çalış, F. A., El, Ö., Kutsal, Y. G., Peker, Ö., Sindel, D., Tüzün, Ş., Yavuz, D. G., Durmaz, B., Akarırmak, Ü., et al. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00799-0 · Cited by 70
Kamycheva, E., Goto, T., & Camargo, C. A. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3791-4 · Cited by 70
Diagnosis and Treatment of Osteoporosis: What Orthopaedic Surgeons Need to Know
Matzkin, E. G., DeMaio, M., Charles, J. F., & Franklin, C. C. (2019) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-18-00600 · Cited by 69
Estimation and projection about the standardized prevalence of osteoporosis in mainland China
Cui, Z., Meng, X., Feng, H., Zhuang, S., Liu, Z., Zhu, T., Ye, K., Xing, Y., Sun, C., Zhou, F., et al. (2019) · Archives of Osteoporosis · doi:10.1007/s11657-019-0670-6 · Cited by 69
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Lunenfeld, B., Mskhalaya, G. J., Zitzmann, M., Corona, G., Arver, S., Kalinchenko, S. Y., Tishova, Y. A., & Morgentaler, A. (2021) · The Aging Male · doi:10.1080/13685538.2021.1962840 · Cited by 68
Shetty, S., Kapoor, N., Naik, D., Asha, H. S., Prabu, S., Thomas, N., Seshadri, M. S., & Paul, T. V. (2014) · Journal of Osteoporosis · doi:10.1155/2014/723238 · Cited by 66
Nayak, S., & Greenspan, S. L. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3437 · Cited by 66
Moreland, B. L., Legha, J. K., Thomas, K. E., & Burns, E. R. (2022) · Journal of Aging and Health · doi:10.1177/08982643221132450 · Cited by 65
For the Osteoporotic Fractures in Men (MrOS) Study Group, Fink, H. A., Litwack‐Harrison, S., Taylor, B. C., Bauer, D. C., ORWOLL, E. S., Lee, C. G., Barrett-Connor, E. L., Schousboe, J. T., Kado, D. M., et al. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3356-y · Cited by 64
Self-citationEffects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
Chen, C., Lane, H., & Lin, C. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.3.238 · Cited by 64
Nanes, M. S., & Kallen, C. B. (2014) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.06.006 · Cited by 64
Diagnostic devices for osteoporosis in the general population: A systematic review
Høiberg, M., Rubin, K. H., Hermann, A. P., Brixen, K., & Abrahamsen, B. (2016) · Bone · doi:10.1016/j.bone.2016.08.011 · Cited by 62
Walsh, J., & Eastell, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.171 · Cited by 62
Self-citationLunenfeld, B., Mskhalaya, G. J., Kalinchenko, S. Y., & Yulia, T. (2013) · The Aging Male · doi:10.3109/13685538.2013.853731 · Cited by 61
Androgen deprivation therapy complications
Allan, C. A., Collins, V., Frydenberg, M., McLachlan, R. I., & Matthiesson, K. L. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0467 · Cited by 60
Vesper, H. W., Wang, Y., Vidal, M., Botelho, J. C., & Caudill, S. P. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.245969 · Cited by 60
Rodrigues, A. M., Canhão, H. M., Marques, A., Ambrósio, C., Borges, J., Coelho, P. S., Costa, L. M. S. F., Fernandes, S., Gonçalves, I., Gonçalves, M., et al. (2018) · PubMed · Cited by 58
Current topics in testosterone replacement of hypogonadal men
Nieschlag, E. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.008 · Cited by 57
Bone health in the elderly cancer patient: A SIOG position paper
Body, J., Terpos, E., TOMBAL, B. F., Hadji, P., Arif, A., Young, A., Aapro, M., & Coleman, R. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.10.004 · Cited by 56
The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial
Czerwinski, E. J., Cardona, J., Plebanski, R., Recknor, C. P., Vokes, T., Saag, K. G., Binkley, N., Lewiecki, E. M., Adachi, J. D., Knychas, D., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4719 · Cited by 55
Self-citationHerrera, A., Lobo-Escolar, A., Mateo, J., Gil, J., Ibarz, E., & Gracia, L. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i12.223 · Cited by 55
Kim, D. K., Lee, J. Y., Kim, K. J., Hong, N., Kim, J. W., Hah, Y. S., Koo, K. C., Kim, J. H., & Cho, K. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010113 · Cited by 54
Alibhai, S. M. H., Mohamedali, H. Z., Gulamhusein, H., Panju, A. H., Breunis, H., Timilshina, N., Fleshner, N. E., Krahn, M. D., Naglie, G., Tannock, I. F., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2343-4 · Cited by 54
Osteoporosis Diagnosis and Medical Treatment
Warriner, A. H., & Saag, K. G. (2013) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2013.01.005 · Cited by 53
Osteoporosis in older men: Recent advances in pathophysiology and treatment
Laurent, M. R., Gielen, E., Claessens, F., Boonen, S., & Vanderschueren, D. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.04.010 · Cited by 53
Loures, M. A. A. D. R., Zerbini, C. A. F., Danowski, J. S., Pereira, R. M. R., Moreira, C., de Paula, A. P., Castro, C. H. D. M., Szejnfeld, V. L., de Mendonça, L. M. C., Radominiski, S. C., et al. (2017) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2017.06.002 · Cited by 52
Dudek, P., Kozakowski, J., & Zgliczyński, W. (2017) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2017.68595 · Cited by 52
Sex hormones, sex hormone binding globulin, and vertebral fractures in older men
Cawthon, P. M., Schousboe, J. T., Harrison, S. L., Ensrud, K. E., Black, D., Cauley, J. A., Cummings, S. R., LeBlanc, E. S., Laughlin, G. A., Nielson, C. M., et al. (2016) · Bone · doi:10.1016/j.bone.2016.01.009 · Cited by 51
Self-citation
Metadata
- Authors
- Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S.
- Affiliations
- Mercy Health (US)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Mayo Clinic (US)
- University of Sheffield (GB)
- Oregon Health & Science University (US)
- Harvard University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-06-01
- Volume
- 97
- Issue
- 6
- Pages
- 1802-1822
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2075195284
- Cited by
- 611
- References
- 216
- Citations by year
- 2026: 38 · 2025: 42 · 2024: 32 · 2023: 46 · 2022: 53 · 2021: 41 · 2020: 49 · 2019: 36 · 2018: 48 · 2017: 39 · 2016: 42 · 2015: 31 · 2014: 50 · 2013: 51 · 2012: 11
- FWCI
- 48.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- male osteoporosis, osteoporosis management, fracture risk assessment, dual-energy X-ray absorptiometry, bone mineral density, calcium and vitamin D supplementation, weight-bearing exercise, smoking, alcohol consumption, T-score, osteopenia, older men
- MeSH terms
- Aged, Endocrinology, Humans, Male, Middle Aged, Osteoporosis, Risk Factors, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.